Active Pharmaceutical Ingredients Market – Comprehensive

0

Active Pharmaceutical Ingredients Market

The global active pharmaceutical ingredients market is expected to witness a CAGR of around 6% during the forecast period. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some medications contain more than one active pharmaceutical ingredient. Rising prevalence of various diseases coupled with COVID-19 pandemic is expected to drive the active pharmaceutical ingredients market. Additionally, increasing investment in research and development of targeted and specific drugs and pharmacogenetic drugs is also expected to support the growth of the market. Worldwide, the increase in chronic diseases is leading to increased demand for treatment and is having positive impacts on the drug manufacturing market. For example, Istodax, a drug registered by Celgene Co. in 2009 for cancer (cutaneous T-cell lymphoma) grew by 30% in 2018 compared to 2010 which was US$16 million in 2010 and reached 63 million US dollars in 2018.

According to the “UnivDatos Market Insights (UMI)” research report “Active Pharmaceutical Ingredients Market Analysis, 2020”, the active pharmaceutical ingredients market is expected to grow at a CAGR of approximately 6% in 2021-27F.

Request to download an example of this strategic report – https://univdatos.com/get-a-free-sample-form-php/?product_id=20418

Based on synthesis, the market is divided into biotechnology and synthetic. During the forecast period, the biotechnology segment is expected to witness significant growth. This is mainly due to the increasing focus on increasing the precision of biopharmaceutical drugs as well as increasing investment in biotechnology research which is driving the market. Additionally, these drugs also provide patient-specific treatments that increase the effectiveness of the drug with minimal side effects.

On the basis of manufacturer type, the market is categorized into merchant APIs and captive APIs. Among the two, captive API is expected to witness significant growth over the forecast period. This can be attributed to improved marketing strategies as well as increased connectivity associated with innovations in manufacturing. In addition, increasing public investments in pharmaceutical industries in developing countries such as India, China, Brazil, and Mexico are also contributing to the growth of captive APIs.

Based on drug type, the Active Pharmaceutical Ingredients market has been divided into Generic APIs and Innovative APIs. Among them, the innovative API market is expected to grow at a significant rate during the forecast period. Rising prevalence of new diseases and increasing demand for more targeted and effective drugs for the treatment of various chronic diseases are expected to drive the market.

Based on application, the market is categorized into communicable diseases, oncology, diabetes, cardiovascular diseases (CVDs), pain management, respiratory diseases and others. Among them, the cardiovascular segment dominated the market in 2020 owing to the growing prevalence of cardiovascular disorders and growing awareness of the seriousness of heart diseases. However, the oncology segment is expected to grow in the foreseeable future. Sedentary lifestyle, increasing cases of alcohol and tobacco abuse and increasing pollution are some of the main factors responsible for increasing cases of chronic diseases such as cancer and diabetes around the world. Thus, the need for effective treatment and drugs is expected to drive the API market over the forecast period.

Request to download an example of this strategic report – https://univdatos.com/get-a-free-sample-form-php/?product_id=20418

North America will experience significant growth
For a better understanding of the market adoption of Active Pharmaceutical Ingredients industry, the market is analyzed based on its global presence in countries such as North America (United States, Canada and the rest of North America), Europe (Germany, France, Italy, Spain, UK and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the world. During the forecast period, North America is expected to experience the highest CAGR during the forecast period. Moreover, the increase in the geriatric population coupled with the growing number of patients with chronic diseases provides immense opportunities for market players to develop APIs. Additionally, increasing investment in biotechnology and biopharmaceutical industry along with increasing healthcare expenditure in the region are other major factors driving the North America API market.

According to UnivDatos Market Insights (UMI), the major players with considerable market share in the market are Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories Ltd. The players are focusing on launching new solutions and services, partnerships and collaborations with large companies expanding their geographical reach to gain a competitive advantage in the industry.

“Analysis of the Active Pharmaceutical Ingredients Market, 2020” provides comprehensive qualitative and quantitative insights on the potential of the industry, key factors impacting on sales and purchase decisions, hot spots and opportunities available for active pharmaceutical ingredient suppliers around the world. Additionally, the report also encompasses key strategic imperatives for competitor success as well as Strategic Factor Indexing measuring competitors’ capabilities on 16 metrics. This will help companies formulate go-to-market strategies and identify the blue ocean for their offerings.

For more information visit us – https://univdatos.com/report/active-pharmaceutical-ingredient-market/

Market segmentation :
1. By synthesis (biotechnological and synthetic)
2. By Manufacturer Type (Merchant APIs and Captive APIs)
3. By drug type (generic APIs and innovative APIs)
4. By Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases (CVDs), Pain Management, Respiratory Diseases and Others)
5. By Region (North America, Europe, Asia-Pacific, Rest of the World)
6. By company (Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories Ltd)

Answers to key research questions:
1. What are the current and future trends in the Active Pharmaceutical Ingredients industry?
2. How has the industry evolved in terms of type of manufacture and application?
3. How has competition shaped across countries, followed by their comparative factor indexing?
4. What are the key growth drivers and challenges for the Active Pharmaceutical Ingredients industry?
5. What is the customer orientation, buying behavior and expectations of active pharmaceutical ingredient companies in different regions?

Contact us:
UnivDatos (UMI) Market Overview
Email: [email protected]
The Web: https://univdatos.com
Telephone: +91 7838604911

About Us:
UnivDatos Market Insights (UMI), is a passionate market research company and a subsidiary of Universal Data Solutions. Rigorous secondary and primary market research is our USP, which is why the information presented in our reports is based on facts and realistic assumptions. We have worked with over 200 global clients, including some of the Fortune 500 companies. Our clientele praises us for quality information, in-depth analysis, custom research capabilities, and detailed market segmentation.

This press release was published on openPR.

Share.

Comments are closed.